State Ledger
Company profile

Cocrystal Pharma, Inc. CIK 1412486

Ticker
COCP (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bothell, WA 98011
Fiscal year end
2025 (FY)
Market Data
Close
$1.11
Change
+$0.00
Change %
0.00%
Volume
0

COCP · trading date Oct 9, 2026 · previous close $1.11 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.83M
Total assets
$9.71M
Total liabilities
$3.38M
Stockholders' equity
$6.33M
Cash & equivalents
$7.03M
Operating income
-$9.02M
Operating cash flow
-$8.19M
Capital expenditures
$12.0K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$8.20M
Free cash flow margin
—
Liabilities / assets
34.8%
Equity / assets
65.2%
CapEx / revenue
—
Operating cash flow / net income
0.93×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.83M $9.71M $3.38M $6.33M
2024 — -$17.50M $13.46M $3.93M $9.52M
2023 — -$17.98M $31.26M $4.88M $26.38M
2022 — -$38.84M $40.84M $1.27M $39.60M
2021 — -$14.19M $79.39M $1.84M $77.55M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bothell, WA 98011
19805 N. CREEK PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Washington — Public Companies